Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

BACKGROUND AND PURPOSE Numerous different parameters measured by perfusion MR imaging can be used for characterizing gliomas. Parameters derived from 3 different analyses were correlated with histopathologically confirmed grade in gliomas to determine which parameters best predict tumor grade. METHODS Seventy-four patients with gliomas underwent dynamic susceptibility contrast-enhanced MR imaging (DSC MR imaging). Data were analyzed by 3 different algorithms. Analysis 1 estimated relative cerebral blood volume (rCBV) by using a single compartment model. Analysis 2 estimated fractional plasma volume (V(p)) and vascular transfer constant (K(trans)) by using a 2-compartment pharmacokinetic model. Analysis 3 estimated absolute cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT) by using a single compartment model and an automated arterial input function. The Mann-Whitney U test was used make pairwise comparisons. Binary logistic regression was used to assess whether rCBV, V(p), K(trans), CBV, CBF, and MTT can discriminate high- from low-grade tumors. RESULTS rCBV was the best discriminator of tumor grade ype, followed by CBF, CBV, and K(trans). Spearman rank correlation factors were the following: rCBV = 0.812 (P < .0001), CBF = 0.677 (P < .0001), CBV = 0.604 (P < .0001), K(trans) = 0.457 (P < .0001), V(p) = 0.301 (P =.009), and MTT = 0.089 (P = .448). rCBV was the best single predictor, and K(trans) with rCBV was the best set of predictors of high-grade glioma. CONCLUSION rCBV, CBF, CBV K(trans), and V(p) measurements correlated well with histopathologic grade. rCBV was the best predictor of glioma grade, and the combination of rCBV with K(trans) was the best set of metrics to predict glioma grade.

[1]  J. Petrella,et al.  MR perfusion imaging of the brain: techniques and applications. , 2000, AJR. American journal of roentgenology.

[2]  Mark S. Cohen,et al.  Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.

[3]  Michael H Lev,et al.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.

[4]  A. Jackson,et al.  Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. , 2003, The British journal of radiology.

[5]  Glyn Johnson,et al.  Measuring blood volume and vascular transfer constant from dynamic, T  2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[6]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[7]  W. Dillon,et al.  Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. , 2002, Academic radiology.

[8]  M Takahashi,et al.  Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.

[9]  K. Hess,et al.  Correlation between dynamic MRI and outcome in patients with malignant gliomas , 1998, Neurology.

[10]  Peter Vajkoczy,et al.  Vascular microenvironment in gliomas. , 2004, Cancer treatment and research.

[11]  E. Cochran,et al.  Oligodendroglioma: pathology and molecular biology. , 2002, Surgical neurology.

[12]  Glyn Johnson,et al.  Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.

[13]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[14]  P. Burger,et al.  Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. , 1986, Seminars in oncology.

[15]  Nancy J Fischbein,et al.  Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. , 2005, AJNR. American journal of neuroradiology.

[16]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[17]  C. Zimmer,et al.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.

[18]  Glyn Johnson,et al.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.

[19]  Richard S. J. Frackowiak,et al.  Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.

[20]  B R Rosen,et al.  Clinical applications of intracranial perfusion MR imaging. , 1999, Neuroimaging clinics of North America.

[21]  Mitsutoshi Nakamura,et al.  Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas , 2002, Acta Neuropathologica.

[22]  W. J. Lorenz,et al.  Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. , 1994, Radiology.

[23]  V. Haughton,et al.  Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. , 2003, Radiology.

[24]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[25]  J. Detre,et al.  Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla , 2005, Journal of magnetic resonance imaging : JMRI.

[26]  Alan Jackson,et al.  Comparative study of methods for determining vascular permeability and blood volume in human gliomas , 2004, Journal of magnetic resonance imaging : JMRI.

[27]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[28]  Z L Gokaslan,et al.  Limitations of stereotactic biopsy in the initial management of gliomas. , 2001, Neuro-oncology.

[29]  Jin-Suh Kim,et al.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. , 2002, AJR. American journal of roentgenology.

[30]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[31]  D. McDonald,et al.  Significance of blood vessel leakiness in cancer. , 2002, Cancer research.

[32]  W P Dillon,et al.  Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. , 2001, Academic radiology.

[33]  Glyn Johnson,et al.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.

[34]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[35]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[36]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[37]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[38]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[39]  B R Rosen,et al.  Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. , 1996, AJNR. American journal of neuroradiology.